clinical trials

Will third trial be the charm for Alkermes' depression drug?
Will third trial be the charm for Alkermes' depression drug?
Fierce Biotech
Alkermes
clinical trials
ALKS 5461
major depressive disorder
Flag link:
Drug developers face increasingly risky tightrope walk between top-line results and hard data
Drug developers face increasingly risky tightrope walk between top-line results and hard data
Endpoints
drug development
clinical trials
late stage data
Roche
Perjeta
Flag link:
FDA gives OK, Cel-Sci clinical hold finally lifted
FDA gives OK, Cel-Sci clinical hold finally lifted
BioPharma Dive
FDA
Cell-Sci
Multikine
clinical trials
head and neck cancer
Flag link:
In a rare misfire, Regeneron scraps its RSV drug after a PhIII failure
In a rare misfire, Regeneron scraps its RSV drug after a PhIII failure
Endpoints
Regeneron
RSV
clinical trials
REGN2222
suptavumab
Flag link:
A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
NY Times, NY
cancer
oncology
clinical trials
patients
Flag link:
Ophthotech completes clean sweep of phase 3 trial flops
Ophthotech completes clean sweep of phase 3 trial flops
Fierce Biotech
Ophthotech
clinical trials
Fovista
wet age-related macular degeneration
Flag link:
Allegro’s diabetic macular edema trial meets primary endpoint
Allegro’s diabetic macular edema trial meets primary endpoint
Drug Delivery Business News
Allegro
diabetic macular edema
clinical trials
Luminate
Flag link:
Former CDC Director: Medicine Should Look Beyond Randomized Controlled Trials
Former CDC Director: Medicine Should Look Beyond Randomized Controlled Trials
RAPS.org
CDC
clinical trials
FDA
Flag link:
Lilly's acute migraine drug succeeds in late-stage study
Lilly's acute migraine drug succeeds in late-stage study
Yahoo/Reuters
Eli Lilly
migraines
clinical trials
Lasmiditan
Flag link:
Forget BMY's Q2 Earnings, Watch Out For Opdivo Trials Going Forward
Forget BMY's Q2 Earnings, Watch Out For Opdivo Trials Going Forward
Forbes
Bristol-Myers Squibb
Opdivo
clinical trials
Flag link:
Milestone Pharma preps a leap into PhIII cardio study with $55M round backed by Novo
Milestone Pharma preps a leap into PhIII cardio study with $55M round backed by Novo
Endpoints
Milestone Pharma
clinical trials
etripamil
paroxysmal supraventricular tachycardia
Flag link:
Patient Anonymity in Clinical Trials Supported by Two De-Identification Methods
Patient Anonymity in Clinical Trials Supported by Two De-Identification Methods
Xtalks
clinical trials
patients
anonymity
Flag link:
Bristol-Myers and Clovis will partner for cancer combination trials
Bristol-Myers and Clovis will partner for cancer combination trials
Marketwatch
clinical trials
Bristol-Myers Squibb
Clovis Oncology
Opdivo
Rubraca
Flag link:
InVivo Therapeutics shares tank after a third patient death in lead study
InVivo Therapeutics shares tank after a third patient death in lead study
Endpoints
Invivo Therapeutics
Neural-Spinal Scaffold
clinical trials
devices
spinal cord implant
Flag link:
AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment
AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment
TheStreet.com
AstraZeneca
Mystic
clinical trials
M&A
Pfizer
Merck
Flag link:
AstraZeneca Cancer Drug Failure Doesn't Bode Well For Bristol Myers
AstraZeneca Cancer Drug Failure Doesn't Bode Well For Bristol Myers
TheStreet.com
AstraZeneca
clinical trials
Mystic
Bristol-Myers Squibb
Opdivo
Flag link:
AstraZeneca lung cancer immunotherapy trial failure sends shares plunging
AstraZeneca lung cancer immunotherapy trial failure sends shares plunging
Stat
AstraZeneca
Mystic
immuno-oncology
clinical trials
tremelimumab
Imfinzi
Flag link:
Comparing drug and device trials
Comparing drug and device trials
Mass Device
clinical trials
devices
Flag link:
An Exciting New Drug Is in Clinical Trials for Aurinia Pharmaceuticals
An Exciting New Drug Is in Clinical Trials for Aurinia Pharmaceuticals
Motley Fool
clinical trials
Aurinia Pharmaceuticals
FDA
voclosporin
lupus
kidney disease
Flag link:
Neuralstem’s lead drug crumbles in PhII, adding to a litany of failures for depression drugs and blasting shares
Neuralstem’s lead drug crumbles in PhII, adding to a litany of failures for depression drugs and blasting shares
Endpoints
Neuralstem
clinical trials
NSI-189
clinical depression
Flag link: